Drug Hepatotoxicity, An Issue of Clinics in Liver Disease
2021
Elsevier - Health Sciences Division (Verlag)
978-0-323-49652-0 (ISBN)
Elsevier - Health Sciences Division (Verlag)
978-0-323-49652-0 (ISBN)
Dr. Rustgi has assembled the leading experts in the management of Heptatitis B to present the current treatment and clinical course for diagnosis and management of the disease. Articles are devoted to: Drug metabolism in the liver; Mechanism of Liver Damage including the RUCAM scale; Drug-induced acute liver failure; Epidemiology and genetic risk factors; Adverse drug reactions: type A (intrinsic or pharmacological) or type B (idiosyncratic); Pathology of injury including phenotypes; The clinical course of drug-induced liver disease; Environmental factors of drug hepatotoxicity; Newer agents in drug hepatotoxicity; Drug hepatotoxicity: herbal products; Drug hepatotoxicity: models including "human on a chip and zebrafish; Acute and chronic liver failure from drugs: impact on the kidney; and Management of acute hepatotoxicity including medical agents and liver support systems. Readers will come away with the cutting edge science behind the latest innovations in the treatment of Hepatitis B.
Erscheinungsdatum | 01.03.2017 |
---|---|
Reihe/Serie | The Clinics: Internal Medicine |
Verlagsort | Philadelphia |
Sprache | englisch |
Maße | 152 x 229 mm |
Gewicht | 500 g |
Themenwelt | Medizinische Fachgebiete ► Innere Medizin ► Hepatologie |
Studium ► 2. Studienabschnitt (Klinik) ► Pharmakologie / Toxikologie | |
ISBN-10 | 0-323-49652-0 / 0323496520 |
ISBN-13 | 978-0-323-49652-0 / 9780323496520 |
Zustand | Neuware |
Haben Sie eine Frage zum Produkt? |
Mehr entdecken
aus dem Bereich
aus dem Bereich
Diagnostik, Differenzialdiagnostik, Therapieansätze
Buch (2016)
Thieme (Verlag)
CHF 148,80
Buch | Softcover (2020)
Wiley-Blackwell (Verlag)
CHF 119,95